Cellebrite DI Ltd.
94 Shlomo Shmelzer Road
Petah Tikva, Israel
October 4, 2021
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Technology
100 F Street, NE
Washington, D.C. 20549
| Attn: | Jan Woo |
| Matthew Crispino | |
| Re: | Cellebrite DI Ltd. |
| Registration Statement on Form F-1 | |
| Filed September 27, 2021, as amended | |
| File No. 333-259826 |
Dear Ms. Woo and Mr. Crispino:
Pursuant to Rule 461 of the rules and regulations promulgated under the Securities Act of 1933, as amended, Cellebrite DI Ltd. respectfully requests that the effective date of the above-referenced Registration Statement be accelerated so as to permit it to become effective at 4:00 p.m. Washington D.C. time on October 6, 2021, or as soon thereafter as practicable.
Please call Colin Diamond of White & Case LLP at (212) 819-8754 to provide notice of the effectiveness of the Registration Statement.
[Signature Page Follows]
| Very truly yours, | ||
| Cellebrite DI Ltd. | ||
| By: | /s/ Yossi Carmil | |
Name: Title: | Yossi Carmil Chief Executive Officer | |
| cc: | Dana Gerner, Cellebrite DI Ltd. | |
Colin Diamond, White & Case LLP |
